Missed your post, tc. Thanks for the explanation.
Post# of 36537
(Total Views: 262)
Posted On: 11/24/2020 1:34:35 PM
Missed your post, tc. Thanks for the explanation. Adding more support to Beasley's earlier post, a year end State of the Company address, similar to what Joe provided when he took over in 2017, is well-warranted.
What is it going to take to move the ball across the goal post; two balls and two goal posts, if you count GNBT and NGIO as separate entities. What is the plan for bringing NGIO public? What role, if any, is Donohoe playing? If not a SPAC, what is the instrument to propel NGIO to public status? Does COVID enhance or detract from the MSO model? Are there pieces that can be sold off that are dead wood to us, but may provide funds to enhance other parts of the business.
You get the picture. There are so many moving pieces, including those that no longer move, a detailed update at the end of the year would be timely and appreciated. I wouldn't consider this a CC, although there could be a Q&A session.
What is it going to take to move the ball across the goal post; two balls and two goal posts, if you count GNBT and NGIO as separate entities. What is the plan for bringing NGIO public? What role, if any, is Donohoe playing? If not a SPAC, what is the instrument to propel NGIO to public status? Does COVID enhance or detract from the MSO model? Are there pieces that can be sold off that are dead wood to us, but may provide funds to enhance other parts of the business.
You get the picture. There are so many moving pieces, including those that no longer move, a detailed update at the end of the year would be timely and appreciated. I wouldn't consider this a CC, although there could be a Q&A session.
(1)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼